Evercore ISI Group has initiated coverage on iRhythm Technologies Inc (IRTC) with an In-Line rating as of September 22, 2025. The current share price stands at $178.53.
This rating marks Evercore's first assessment of iRhythm's investment potential, reflecting their research into the company's business model and industry dynamics. iRhythm Technologies, based in San Francisco, specializes in digital healthcare, providing device-based technology for ambulatory cardiac monitoring services. The company offers three Zio System options: the Zio Monitor System, Zio XT System, and Zio AT System.
As of November 20, 2025, iRhythm's market capitalization is $5.5 billion, with a trailing twelve months (TTM) earnings per share (EPS) of -1.62. Upcoming earnings reports are scheduled for July 29, 2026, with an estimated EPS of -0.11 and revenue of $221.7 million, and for April 29, 2026, with an estimated EPS of -0.46 and revenue of $195.2 million. Recent earnings performance has shown improvement, with a Q3 2025 EPS of -0.06, significantly better than the estimated -0.32, reflecting an 81% surprise.
Analyst ratings provide insight into market perceptions based on financial models and assumptions. However, they should be considered alongside company fundamentals and industry trends when making investment decisions. As of November 1, 2025, the consensus among analysts is a Buy rating, with 9 Strong Buy, 10 Buy, and 3 Hold ratings noted in the latest evaluations.